Clinical experience of fast neutron therapy for carcinoma of the uterine cervix. 1985

S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu

Fast neutron therapy for locally advanced or radioresistant malignant tumors was started in November 1975 at the National Institute of Radiological Sciences (NIRS), Chiba, Japan. To evaluate the effectiveness of fast neutron therapy, mixed neutron-photon fractionated irradiation, on squamous cell carcinoma of the uterine cervix, 98 patients with Stage IIIb disease were examined to study the correlation between local control rate and histological types. The local control rate after neutron-mixed beam therapy was 73%, which decreased to 66% with photon irradiation. The five year survival rate was 49% for patients receiving neutron therapy and 49% for those receiving photon therapy. There was no statistical significance between neutron and photon therapy; we then attempted to analyze histological types to check for any gain using neutron therapy. This study was a nonrandomized trial. The preliminary results however, gave us useful information for the next of neutron therapy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010315 Particle Accelerators Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Betatrons,Linear Accelerators,Accelerator, Linear,Accelerator, Particle,Accelerators, Linear,Accelerators, Particle,Betatron,Linear Accelerator,Particle Accelerator
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005214 Fast Neutrons Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts. Fast Neutron,Neutron, Fast,Neutrons, Fast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
February 1981, International journal of radiation oncology, biology, physics,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
January 1983, Progress in clinical and biological research,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
January 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
January 1994, Acta oncologica (Stockholm, Sweden),
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
December 1982, International journal of radiation oncology, biology, physics,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
May 1953, Wiener klinische Wochenschrift,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
April 1994, Gynecologic oncology,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
February 2006, Radiation medicine,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
July 1958, Cleveland Clinic quarterly,
S Morita, and T Arai, and T Nakano, and T Ishikawa, and H Tsunemoto, and K Fukuhisa, and T Kasamatsu
October 1958, Cleveland Clinic quarterly,
Copied contents to your clipboard!